CD34 and myelodysplastic syndrome: Conversely, olaparib sensitivity of normal BM, CD34-enriched mobilized peripheral blood and purified CD34+ samples (IC50 range: 18.5–27.0 μM) was markedly higher than that of MDS cells (Figure S1B), in agreement with previous findings [5,10,12,29].